Visualizing beta cells in patients with remission of T2DM after bariatric surgery - Visualizing beta cells after bariatric surgery

Radboud University Medical Center Nijmegen0 个研究点目标入组 24 人开始时间: 2015年1月7日最近更新: 2015年3月9日

适应症

试验速览

暂无简介。

•Responders:
•- Obese T2D patient who has undergone RYGB at least one year earlier
•- Signed informed consent
•- Complete resolution of T2DM after surgery (HbAl c in normal range, fasting glucose <100 mg/dl for at least I
•year in the absence of active pharmacologic therapy or ongoing procedures)
•non-responders:
•- Obese T2D patient who has undergone RYGB at least one year earlier
•- Signed informed consent
•- No complete resolution of T2DM after surgery (still requires treatment with oral hypoglycaemic agents or insulin)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 24
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Previous treatment with synthetic Exendin (Exenatide, Byetta@) or Dipeptidyl-Peptidase lV inhibitors
•- Breast feeding
•- Pregnancy or the wish to become pregnant within 6 months
•- Calculated creatinine clearance below 4Oml/min
•- Age . 18 years
•- No signed informed consent

发起方

Radboud University Medical Center Nijmegen